1. Introduction {#sec1-nutrients-09-00996}
===============

Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in women of reproductive age, with a prevalence of 6--18%, depending on the diagnostic criteria used and the population studied \[[@B1-nutrients-09-00996],[@B2-nutrients-09-00996],[@B3-nutrients-09-00996]\]. The condition is underpinned by insulin resistance (IR) and hyperandrogenism. These hormonal abnormalities both contribute to clinical features including hirsutism or acne, oligo-/anovulation and polycystic ovarian morphology, type 2 diabetes (DM2), metabolic syndrome and cardiovascular disease \[[@B4-nutrients-09-00996],[@B5-nutrients-09-00996],[@B6-nutrients-09-00996],[@B7-nutrients-09-00996]\]. PCOS also accounts for the majority of cases of anovulatory infertility \[[@B8-nutrients-09-00996]\], and women with PCOS have an increased risk of pregnancy and neonatal complications \[[@B9-nutrients-09-00996]\]. Women with PCOS also have a higher risk of psychological complications, including depression and anxiety \[[@B10-nutrients-09-00996]\].

The etiology of PCOS is complex and poorly understood. Both genetic and environment factors contribute to the syndrome \[[@B11-nutrients-09-00996]\], and both gonadotropin hypersecretion and IR increase androgen secretion \[[@B12-nutrients-09-00996],[@B13-nutrients-09-00996],[@B14-nutrients-09-00996]\]. Women with PCOS appear to have a higher rate of weight gain and a higher prevalence of overweight, obesity and central obesity, compared to women without PCOS \[[@B15-nutrients-09-00996],[@B16-nutrients-09-00996],[@B17-nutrients-09-00996]\]. Obesity, especially central obesity, worsens the clinical and biochemical presentation of the syndrome, contributing to IR, hyperandrogenism, reproductive disorders, diabetes and cardiovascular disease \[[@B18-nutrients-09-00996],[@B19-nutrients-09-00996],[@B20-nutrients-09-00996]\]. Weight loss, in turn, improves all the features of PCOS, and lifestyle (diet, physical activity and behavior) changes and weight management are recommended as first line treatment for PCOS \[[@B21-nutrients-09-00996],[@B22-nutrients-09-00996]\] to improve hormonal disturbances and to prevent future reproductive and metabolic complications. Preconception lifestyle interventions and weight loss are also recommended before infertility treatment is initiated \[[@B23-nutrients-09-00996]\], and lead to higher ovulation rates compared to oral contraceptive pretreatment \[[@B24-nutrients-09-00996]\].

It has been proposed that weight management interventions may be less effective in women with PCOS compared to those without PCOS given the higher rate of longitudinal weight gain in PCOS \[[@B17-nutrients-09-00996]\]. This may be related to the hormonal aberrations of PCOS such as hyperandrogenemia or IR, contributing to abnormalities in energy homeostasis and dietary intake including gut hormone regulation \[[@B25-nutrients-09-00996],[@B26-nutrients-09-00996]\], or an altered metabolism due to reduced postprandial thermogenesis \[[@B27-nutrients-09-00996]\]. However, the literature is limited and contradictory. The aim of this systematic review is thus to assess the effect of lifestyle (dietary and non-dietary) weight management interventions on anthropometric, reproductive and metabolic outcomes in women with PCOS, compared to women without PCOS.

2. Materials and Methods {#sec2-nutrients-09-00996}
========================

2.1. Selection Criteria {#sec2dot1-nutrients-09-00996}
-----------------------

This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement checklist \[[@B28-nutrients-09-00996]\]. The detailed PICO (Population, Intervention, Comparison, Outcome) framework in [Supplementary Table S1](#app1-nutrients-09-00996){ref-type="app"}, established a priori, was used to include and exclude articles for this systematic review. Briefly, articles were included if they reported a study that compared women with PCOS to women without PCOS; following a weight management intervention; and investigated anthropometric, fertility, reproductive non-fertility, metabolic, quality of life or emotional wellbeing outcomes. The primary outcome was weight management defined as either weight loss, weight maintenance or prevention of weight gain. Secondary anthropometric, reproductive, metabolic and psychological outcomes are listed in [Table S1](#app1-nutrients-09-00996){ref-type="app"} and were analysed based on the most complete data, which were body mass index (BMI), waist circumference for fat distribution, computed tomography for fat and lean mass, number of ovulations, total testosterone, sex hormone-binding globulin (SHBG), free androgen index (FAI), fasting glucose, oral glucose tolerance test (OGTT), fasting insulin, total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triglycerides, and blood pressure.

2.2. Systematic Search for Evidence {#sec2dot2-nutrients-09-00996}
-----------------------------------

A systematic search ([Supplementary Table S2](#app1-nutrients-09-00996){ref-type="app"}) was developed incorporating terms related to weight management (including lifestyle, behaviour, pharmacological, surgical and complementary and alternative interventions) and combined with terms related to PCOS. The search strategy was limited to English language articles and there were no limits on year of publication. The following electronic databases were searched via the OVID platform to identify relevant literature up to May 2017: Ovid MEDLINE(R) 1946 to Present with Daily Update; Ovid MEDLINE(R) In-Process and Other Non-Indexed Citations; Evidence-Based Medicine (EBM) Reviews incorporating Cochrane Database of Systematic Reviews, EBM Reviews---ACP Journal Club, EBM Reviews---Database of Abstracts of Reviews of Effects, EBM Reviews---Cochrane Central Register of Controlled Trials, EBM Reviews---Cochrane Methodology Register, EBM Reviews---Health Technology Assessment, EBM Reviews---National Health Service (NHS) Economic Evaluation Database; PsycINFO; and EMBASE. CINAHL Plus was searched separately on the same date. Bibliographies of relevant articles were also searched for identification of additional studies.

2.3. Inclusion of Studies {#sec2dot3-nutrients-09-00996}
-------------------------

To determine the literature to be assessed further, one trained reviewer (J.K. for search to 23 September 2015 and E.C.T for search to 11 May 2017) screened the titles, abstract sections and keywords of every article retrieved by the search strategy using the selection criteria described in [Table S1](#app1-nutrients-09-00996){ref-type="app"}. Full articles were retrieved for further assessment if the information given suggested that the article met the selection criteria, or if it was unclear. Three additional reviewers were consulted throughout the screening process.

2.4. Quality Appraisal of the Evidence {#sec2dot4-nutrients-09-00996}
--------------------------------------

Methodological quality, in terms of risk of bias, of the included studies was assessed by two reviewers (J.K. and E.C.T.) in consultation with experienced reviewers (M.M. and L.J.M.) using criteria developed a priori \[[@B29-nutrients-09-00996]\], designed for cohort studies. Individual quality items were investigated using a descriptive component approach that assessed selection bias, performance bias, attrition bias, reporting bias, potential confounding, and appropriateness of statistical analysis. Any disagreement or uncertainty was resolved by discussion among authors to reach a consensus. Using this approach, each study was allocated a risk of bias rating. Where there was more than one article describing a study, all articles were used to complete one risk of bias assessment on the study.

2.5. Data Extraction {#sec2dot5-nutrients-09-00996}
--------------------

Double data extraction, according to the selection criteria described in [Table S1](#app1-nutrients-09-00996){ref-type="app"} was conducted by two independent reviewers for the original search (J.K. and A.J.) and by two independent reviewers for the updated search (A.J. and E.C.T.). Information was collected on relevant outcome data and included point estimates, measures of variability and number of participants. Where there was more than one article describing a study, data from the most current and comprehensive article was extracted, and any additional outcome data reported in additional articles were subsequently extracted.

2.6. Data Synthesis {#sec2dot6-nutrients-09-00996}
-------------------

Due to the heterogeneity in interventions, a meta-analysis was not performed, results are thus presented narratively and in tabular form. Publication bias could not be assessed due to the lack of meta-analysis as this requires a meta-analysis to be performed on 10 or more studies. All studies reported baseline and endpoint values, except for two studies that reported the difference from baseline to post-intervention. Outcome data has been excluded in instances where only the mean was presented with no corresponding variance data (standard deviation (SD), standard error (SE), or confidence interval (CI)). Where necessary, unit conversions were performed so that results are presented in SI units; in some instances, where conversion factors could not be obtained, the unit from the original manuscript has been retained.

3. Results {#sec3-nutrients-09-00996}
==========

The search returned 3264 articles ([Figure 1](#nutrients-09-00996-f001){ref-type="fig"}). Fifty-nine full text articles were retrieved for further evaluation and 17 articles \[[@B30-nutrients-09-00996],[@B31-nutrients-09-00996],[@B32-nutrients-09-00996],[@B33-nutrients-09-00996],[@B34-nutrients-09-00996],[@B35-nutrients-09-00996],[@B36-nutrients-09-00996],[@B37-nutrients-09-00996],[@B38-nutrients-09-00996],[@B39-nutrients-09-00996],[@B40-nutrients-09-00996],[@B41-nutrients-09-00996],[@B42-nutrients-09-00996],[@B43-nutrients-09-00996],[@B44-nutrients-09-00996],[@B45-nutrients-09-00996],[@B46-nutrients-09-00996]\] reporting 14 studies met the inclusion criteria. Of these 17 articles, one study was reported across two articles \[[@B31-nutrients-09-00996],[@B32-nutrients-09-00996]\] and one study \[[@B35-nutrients-09-00996]\] reported data across different time points \[[@B36-nutrients-09-00996],[@B37-nutrients-09-00996]\]. Two studies reported data from two intervention groups, respectively \[[@B38-nutrients-09-00996],[@B39-nutrients-09-00996]\]. A table of studies, excluded based on full text, is found in [Supplementary Table S3](#app1-nutrients-09-00996){ref-type="app"}: Table of Excluded Studies. All between group comparisons presented here are presented as the authors reported that data and is per protocol for all analyses.

3.1. Characteristics and Quality of Included Studies {#sec3dot1-nutrients-09-00996}
----------------------------------------------------

The characteristics of included studies are reported in [Table 1](#nutrients-09-00996-t001){ref-type="table"}. All studies were comparative/parallel design. Two were designed as randomized controlled studies (RCTs) but comprised two intervention groups, respectively, and were used as comparative studies \[[@B38-nutrients-09-00996],[@B39-nutrients-09-00996]\]. Five studies had a moderate risk of bias, whilst nine studies had a high risk of bias ([Supplementary Table S4](#app1-nutrients-09-00996){ref-type="app"}). Interventions varied across the included studies (diet, diet + behavior change program, diet + Metformin, diet + anti-obesity drug, anti-obesity drug, diet + anti-obesity drug + exercise, bariatric surgery, and various exercise training programs), as did the duration of interventions. Nine studies were designed with the specific aim of weight loss \[[@B34-nutrients-09-00996],[@B37-nutrients-09-00996],[@B38-nutrients-09-00996],[@B39-nutrients-09-00996],[@B41-nutrients-09-00996],[@B42-nutrients-09-00996],[@B43-nutrients-09-00996],[@B45-nutrients-09-00996],[@B46-nutrients-09-00996]\], while the remaining five studies did not state if the aim was weight loss \[[@B30-nutrients-09-00996],[@B31-nutrients-09-00996],[@B33-nutrients-09-00996],[@B40-nutrients-09-00996],[@B44-nutrients-09-00996]\]. The sample size of the studies varied from 31 to 1016.

3.2. Outcomes: Anthropometric {#sec3dot2-nutrients-09-00996}
-----------------------------

### 3.2.1. Weight {#sec3dot2dot1-nutrients-09-00996}

Six studies including eight intervention groups reported weight as endpoint data \[[@B31-nutrients-09-00996],[@B38-nutrients-09-00996],[@B39-nutrients-09-00996],[@B42-nutrients-09-00996],[@B45-nutrients-09-00996],[@B46-nutrients-09-00996]\], whilst a further three studies reported change in weight \[[@B34-nutrients-09-00996],[@B41-nutrients-09-00996],[@B43-nutrients-09-00996]\], and one study reported the estimated difference in weight from baseline to post-intervention \[[@B44-nutrients-09-00996]\] ([Table 2](#nutrients-09-00996-t002){ref-type="table"}). Five of the studies reported that the difference in weight post-intervention or the change in weight from baseline between the PCOS and non-PCOS groups was not statistically significantly different, whilst the remainder of studies did not report a *p*-value.

### 3.2.2. Body Mass Index (BMI) {#sec3dot2dot2-nutrients-09-00996}

Thirteen intervention groups from 12 studies \[[@B30-nutrients-09-00996],[@B31-nutrients-09-00996],[@B33-nutrients-09-00996],[@B36-nutrients-09-00996],[@B38-nutrients-09-00996],[@B40-nutrients-09-00996],[@B41-nutrients-09-00996],[@B42-nutrients-09-00996],[@B43-nutrients-09-00996],[@B44-nutrients-09-00996],[@B45-nutrients-09-00996],[@B46-nutrients-09-00996]\] reported BMI ([Table 2](#nutrients-09-00996-t002){ref-type="table"}). One study reported a statistically significant difference in BMI following bariatric surgery (*p* = 0.013), with women with PCOS having a lower BMI post-surgery than women without PCOS \[[@B45-nutrients-09-00996]\]. This study, however, had a high risk of bias, with a number of key elements of the study protocol not reported and should therefore be interpreted with caution. Three studies reported a non-statistically significant difference in BMI between the two groups, whilst eight studies did not report a *p*-value.

### 3.2.3. Waist Circumference (WC) {#sec3dot2dot3-nutrients-09-00996}

Seven studies including nine intervention groups \[[@B31-nutrients-09-00996],[@B33-nutrients-09-00996],[@B37-nutrients-09-00996],[@B38-nutrients-09-00996],[@B39-nutrients-09-00996],[@B44-nutrients-09-00996],[@B46-nutrients-09-00996]\] reported WC ([Table 2](#nutrients-09-00996-t002){ref-type="table"}). The majority of studies did not compare between-group differences after the interventions, with only one study reporting a non-statistically significant difference in WC between groups following progressive resistance training \[[@B44-nutrients-09-00996]\].

### 3.2.4. Body Composition {#sec3dot2dot4-nutrients-09-00996}

Three intervention groups from two studies \[[@B31-nutrients-09-00996],[@B38-nutrients-09-00996]\] measured body composition with computed tomography (CT). One study with an exercise intervention reported abdominal visceral fat (VF) and subcutaneous fat (SCFAT). Two intervention groups from one study with the interventions diet + Metformin and diet + placebo reported visceral adipose tissue area (VAT) and subcutaneous adipose tissue area (SAT). None of the studies reported whether there was between-group statistical significance ([Table 2](#nutrients-09-00996-t002){ref-type="table"}).

3.3. Outcomes: Fertility {#sec3dot3-nutrients-09-00996}
------------------------

### Ovulation

One study with a diet intervention \[[@B34-nutrients-09-00996]\] reported double the number of ovulatory events in women without PCOS compared to women with PCOS, which was statistically significant ([Table 3](#nutrients-09-00996-t003){ref-type="table"}).

3.4. Outcomes: Reproductive Non-Fertility {#sec3dot4-nutrients-09-00996}
-----------------------------------------

### 3.4.1. Total Testosterone {#sec3dot4dot1-nutrients-09-00996}

Eight intervention groups from seven studies reported total testosterone \[[@B30-nutrients-09-00996],[@B31-nutrients-09-00996],[@B33-nutrients-09-00996],[@B35-nutrients-09-00996],[@B38-nutrients-09-00996],[@B40-nutrients-09-00996],[@B44-nutrients-09-00996]\]. One study with a hypocaloric diet + an anti-obesity drug intervention (Orlistat) \[[@B30-nutrients-09-00996]\], and another study with an anti-obesity drug intervention (Orlistat) + a hypocaloric diet + exercise intervention \[[@B35-nutrients-09-00996]\] reported a statistically significant difference in total testosterone following intervention between the two study groups, with the non-PCOS group having lower values in both studies ([Table 3](#nutrients-09-00996-t003){ref-type="table"}). However, as expected in both studies, the women with PCOS had statistically significantly higher levels of testosterone at baseline than women without PCOS.

### 3.4.2. Sex Hormone-Binding Globulin (SHBG) {#sec3dot4dot2-nutrients-09-00996}

Eight intervention groups from seven studies reported SHBG \[[@B30-nutrients-09-00996],[@B31-nutrients-09-00996],[@B33-nutrients-09-00996],[@B35-nutrients-09-00996],[@B38-nutrients-09-00996],[@B40-nutrients-09-00996],[@B44-nutrients-09-00996]\], with the majority of studies not reporting whether there were between-group statistical significance ([Table 3](#nutrients-09-00996-t003){ref-type="table"}). One study with a hypocaloric diet + anti-obesity drug (Orlistat) intervention \[[@B30-nutrients-09-00996]\] reported a statistically significant difference between groups (*p* \< 0.05) following the intervention; however, there was also a statistically significant difference in SHBG at baseline between the groups (*p* \< 0.05).

### 3.4.3. Free Androgen Index (FAI) {#sec3dot4dot3-nutrients-09-00996}

Five studies reported FAI \[[@B31-nutrients-09-00996],[@B33-nutrients-09-00996],[@B35-nutrients-09-00996],[@B40-nutrients-09-00996],[@B44-nutrients-09-00996]\], with one study with an anti-obesity drug intervention (Orlistat) + a hypocaloric diet + exercise intervention \[[@B35-nutrients-09-00996]\] reporting a statistically significant difference in values post intervention between groups (*p* = 0.021), with women in the non-PCOS group having a lower mean value ([Table 3](#nutrients-09-00996-t003){ref-type="table"}). However, as expected, women with PCOS in this study had a higher mean FAI at baseline (*p* \< 0.001).

3.5. Outcomes: Metabolic {#sec3dot5-nutrients-09-00996}
------------------------

### 3.5.1. Fasting Glucose {#sec3dot5dot1-nutrients-09-00996}

Eleven intervention groups from nine studies reported fasting glucose \[[@B30-nutrients-09-00996],[@B31-nutrients-09-00996],[@B35-nutrients-09-00996],[@B38-nutrients-09-00996],[@B39-nutrients-09-00996],[@B40-nutrients-09-00996],[@B43-nutrients-09-00996],[@B44-nutrients-09-00996],[@B46-nutrients-09-00996]\]. The majority of studies did not report whether there were between-group statistical significance, and three studies \[[@B35-nutrients-09-00996],[@B43-nutrients-09-00996],[@B44-nutrients-09-00996]\] reported that there was no statistically significant difference in fasting glucose post-intervention between the two groups ([Table 4](#nutrients-09-00996-t004){ref-type="table"}).

### 3.5.2. Oral Glucose Tolerance Test (OGTT-Glucose) {#sec3dot5dot2-nutrients-09-00996}

Three intervention groups from two studies reported OGTT-glucose \[[@B30-nutrients-09-00996],[@B39-nutrients-09-00996]\]. None of these studies reported whether there were between-group statistical significance following the interventions ([Table 4](#nutrients-09-00996-t004){ref-type="table"}).

### 3.5.3. Fasting Insulin {#sec3dot5dot3-nutrients-09-00996}

Eleven intervention groups from nine studies reported fasting insulin \[[@B30-nutrients-09-00996],[@B31-nutrients-09-00996],[@B33-nutrients-09-00996],[@B35-nutrients-09-00996],[@B38-nutrients-09-00996],[@B39-nutrients-09-00996],[@B40-nutrients-09-00996],[@B44-nutrients-09-00996],[@B46-nutrients-09-00996]\]. Only one of these studies reported a *p*-value for the between-group difference following the interventions (*p* = 0.58) \[[@B44-nutrients-09-00996]\] ([Table 4](#nutrients-09-00996-t004){ref-type="table"}).

### 3.5.4. Lipids {#sec3dot5dot4-nutrients-09-00996}

Four intervention groups from three studies reported results for blood lipids \[[@B31-nutrients-09-00996],[@B35-nutrients-09-00996],[@B39-nutrients-09-00996]\]. One study with an anti-obesity drug intervention (Orlistat) + a hypocaloric diet + exercise intervention \[[@B35-nutrients-09-00996]\] reported a statistically significant difference in total, LDL and HDL cholesterol post-intervention between groups, with women in the PCOS group having lower mean values ([Table 5](#nutrients-09-00996-t005){ref-type="table"}).

### 3.5.5. Blood Pressure (BP) {#sec3dot5dot5-nutrients-09-00996}

Three intervention groups from two studies reported results for BP \[[@B32-nutrients-09-00996],[@B39-nutrients-09-00996]\]. None of the studies reported whether there were between-group statistical significance ([Table 5](#nutrients-09-00996-t005){ref-type="table"}).

4. Discussion {#sec4-nutrients-09-00996}
=============

In this systematic review, we evaluated for the first time the effect of weight management interventions in women with PCOS compared to women without PCOS. We identified 14 studies in 933 women with considerable clinical heterogeneity across a range of lifestyle (dietary and non-dietary) and non-lifestyle weight management interventions including diet, diet + behavior change program, diet + Metformin, diet + anti-obesity drug, anti-obesity drug, diet + anti-obesity drug + exercise, bariatric surgery, and various exercise training programs. Overall, there were no statistically significant differences in weight at the end of an intervention or in change in weight, between groups for five of the interventions included, with the remainder of studies not reporting whether there was a difference between groups post-intervention. For the majority of secondary endpoints, there was little difference between groups. Furthermore, five of the included studies had a moderate risk of bias, whilst nine studies had a high risk of bias.

The included studies are set in a research environment, with structured interventions, isocaloric intake and frequent contact and interaction with trained professionals. This mirrors many structured lifestyle interventions, and like all research in lifestyle interventions, occurred in a motivated research population.

As with all lifestyle intervention studies, our results may not reflect the outcomes of community-based studies or self-induced lifestyle change. Our previous research has shown a greater 10-year weight gain (2.6 kg (95% CI: 1.2--4.0)) in community-based cohort studies \[[@B17-nutrients-09-00996]\], and an elevated prevalence of overweight (risk ratio (RR) (95% CI): 1.95 (1.52, 2.50)), obesity (2.77 (1.88, 4.10)), central obesity (1.73 (1.31, 2.30)) and BMI (2.5 kg/m^2^ (95% CI: 1.9--3.1)) in systematic reviews \[[@B15-nutrients-09-00996]\] of women with PCOS compared to women without PCOS. This may relate to hyperinsulinemia, reduced postprandial thermogenesis \[[@B27-nutrients-09-00996]\], altered metabolic rate \[[@B47-nutrients-09-00996]\], impaired regulation of gut hormones or appetite regulation or limited self-regulation of food intake \[[@B48-nutrients-09-00996],[@B49-nutrients-09-00996],[@B50-nutrients-09-00996]\]. While the evidence here is not reliable enough to state conclusively if there is no difference in the effect of weight management interventions in women with and without PCOS, if this was indeed the case, this could indicate that appetite and self-regulation may be more prominent contributors to weight in PCOS. These mechanisms are more likely to selectively manifest in a free-living environment with ad libitum food intake. Our past longitudinal community cohort studies also show unselected community dwelling women with PCOS report a higher caloric intake, which corresponds closely to higher rates of weight gain \[[@B51-nutrients-09-00996]\]. More research into appetite and self-regulation around food intake are needed in PCOS.

The majority of secondary endpoints were similar between women with and without PCOS following the specified interventions. Similar to weight, a large number of the included studies did not report whether there was a statistically significant difference between groups for secondary endpoints following the intervention. While for a limited number of outcomes, there was a statistically significant difference in these measures at study completion, this difference was also present at baseline indicating that examining the within-group change from baseline to the end of the intervention would be more appropriate. We also report changes in secondary outcomes including total testosterone and SHBG at study completion between women with and without PCOS. However, women with PCOS generally have hyperandrogenism and lower SHBG \[[@B52-nutrients-09-00996]\] and differences at the end of the intervention are again likely related to baseline differences.

Here, it was not possible to determine the relative effectiveness of specific dietary or non-dietary interventions. Based on our findings reported elsewhere \[[@B21-nutrients-09-00996],[@B22-nutrients-09-00996]\], recommendations in PCOS for lifestyle or pharmacological intervention and weight management should mirror those for the general population. These include a diet with reduced energy intake and a weight loss maintenance program for maintaining weight. Pharmacological treatment can increase efficacy of lifestyle interventions \[[@B53-nutrients-09-00996],[@B54-nutrients-09-00996]\]. A recent meta-analysis reported that a metformin plus lifestyle intervention results in more reduction in fat and improved menstrual cyclicity, compared to lifestyle alone in PCOS \[[@B53-nutrients-09-00996]\]. In general populations, a large meta-analysis (*n* = 80 studies, *n* = 26,455 participants) reported that diet interventions in isolation are as effective for short-term (six months) weight loss compared to anti-obesity drugs. Long-term (24 months) weight-loss, however, was greater with anti-obesity drugs \[[@B55-nutrients-09-00996]\]. Overall, bariatric surgery is an option for those who have not responded to these interventions with sufficient weight loss or for those with morbid obesity and co-morbidities \[[@B56-nutrients-09-00996],[@B57-nutrients-09-00996]\]. Overall, the relative efficacy of different weight management interventions in women with and without PCOS warrants further investigation.

The strengths of this study include the comprehensive range of lifestyle and weight management interventions and of obesity-related outcomes studied. We also included studies where weight loss was not the specific goal, broadening applicability of our findings to weight gain prevention, weight maintenance and use in lean women with PCOS. The weaknesses of this review include the inability to statistically combine study results due to clinical heterogeneity. Additionally, this systematic review was limited to studies in English. Many of the included studies did not report numeric differences between groups and relevant data could not be extracted. The identified studies also had moderate to high risk of bias and were generally small with significant drop-outs. Many did not strictly exclude PCOS status in their controls. Future research should address these methodological weaknesses to improve study quality. We also did not prospectively register this review on PROSPERO; however, it was designed in 2012 at which time PROSPERO had only been active for a relatively short amount of time, and it was not yet standard practice for all systematic reviews to be prospectively registered. Additional biases may also have occurred through identifying articles only in English and through not contacting authors for missing data. Detailed reporting of inclusion and exclusion criteria, increased participant numbers, attrition rates, anthropometric measurement protocols, and publishing study protocols are suggested to improve the reliability and validity of future research. Endpoint reporting could also be improved across the range of obesity-related health implications in PCOS, and through the use of a pre-specified list of outcomes similar to that suggested for infertility treatment \[[@B58-nutrients-09-00996]\].

5. Conclusions {#sec5-nutrients-09-00996}
==============

We report on the first systematic review comparing the effectiveness of weight management strategies in women with and without PCOS. Our findings are that there is insufficient evidence to indicate significant differences in weight loss in women with PCOS compared to women without PCOS with lifestyle or weight management strategies. We cannot determine the relative efficacy of different types of weight management interventions and note considerable limitations with the current studies. Further research with larger samples is warranted in controlled clinical trials and free-living environments assessing a full range of defined PCOS and obesity-related health implications. At the current time, recommendations for weight management for the general population should be applied for women with PCOS with some degree of confidence that similar efficacy of structured interventions is likely.
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nutrients-09-00996-t001_Table 1

###### 

Characteristics of included studies.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                                    Design              Country     PCOS Details at Baseline\           Non-PCOS Details at Baseline\   Attrition Rate          Current Medication                                                                           Specific Exclusion Criteria                                                                                                                                                                                                                               Intervention                                                                                                                                                       Outcomes                                             Risk of Bias
                                                                                           N (Completers)                      N (Completers)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  -------------------------------------------------------- ------------------- ----------- ----------------------------------- ------------------------------- ----------------------- -------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------- --------------
  Diamanti-Kandarakis 2007 \[[@B30-nutrients-09-00996]\]   Comparative study   Greece      Age 27.5 ± 5.77\                    Age 32.1 ± 5.64\                Not reported            Not reported                                                                                 Galactorrhea                                                                                                                                                                                                                                              Duration: 24 weeks\                                                                                                                                                Anthropo-metric: BMI\                                Moderate
                                                                                           BMI 35.4 ± 5.31\                    BMI 36.4 ± 6.47\                                                                                                                                                                                                                                                                                                                                                                                               Normal protein diet, 600 kcal/day energy deficit, Orlistat (Xenical^®^, Roche) 120 mg × 3 times daily\                                                             Reproductive: T, SHBG\                               
                                                                                           ESHRE/ASRM\                         *n* = 18                                                                                                                                                                                                                                                                                                                                                                                                       Aim of weight loss: not stated                                                                                                                                     Metabolic: FG, 2HRG, FI                              
                                                                                           *n* = 29                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Moran 2007 \[[@B34-nutrients-09-00996]\]                 Comparative study   Australia   Age 31.7 ± 6.2\                     Age 37.1 ± 4.7\                 PCOS 17%\               No hormonal or insulin-sensitising drugs pre study                                           Pregnancy, breastfeeding                                                                                                                                                                                                                                  Duration: 8 weeks\                                                                                                                                                 Anthropo-metric: Weight, WC\                         Moderate
                                                                                           BMI 35.7 ± 5.8\                     BMI 35.5 ± 5.1\                 Non-PCOS 11%                                                                                                                                                                                                                                                                                                                                                                   Energy restricted diet (two meals daily replaced with commercially available meal replacements) Aim of weight loss: Yes                                            Reproductive: T, SHBG, FAI\                          
                                                                                           ESHRE/ASRM\                         *n* = 17                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Metabolic: FI, lipids\                               
                                                                                           *n* = 15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Others: IL-6, TNF-α                                  

  Hutchison 2011 \[[@B31-nutrients-09-00996]\]\            Comparative study   Australia   BMI \> 27\                          BMI \> 27\                      PCOS 35%\               No hormonal or insulin-sensitising drugs pre study                                           Diabetes, adrenal disorders, recent weight change, regular physical activity, pregnancy, breastfeeding, smoking                                                                                                                                           Duration: 12 weeks supervised intensified exercise training 60 min three times weekly\                                                                             Anthropo-metric: WC, Weight, BMI, VF, SCFAT\         Moderate
  Harrison 2012 \[[@B32-nutrients-09-00996]\]                                              (37.4 ± 1.5)\                       (35.7 ± 1.3)\                   Non-PCOS 43%                                                                                                                                                                                                                                                                                                                                                                   Aim of weight loss: not stated                                                                                                                                     Reproductive: T, SHBG, FAI\                          
                                                                                           Age 20--40\                         Age 20-40\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Metabolic: FG, FI, lipids, BP                        
                                                                                           (29.5 ± 1.4)\                       (35.0 ± 1.1)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                           NIH\                                *n* = 8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                           *n* = 13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Cheang 2016 \[[@B43-nutrients-09-00996]\]                Comparative study   USA         Age 26.9 ± 4.6\                     Age 27.5 ± 5.7\                 PCOS 53%\               No unstable medication use for 6 months for disorders such as hypertension or dyslipidemia   Weight loss attempts in 3 months pre study, diabetes, pulmonary, cardiac, renal, neurologic, hepatic, psychiatric, infectious, neoplastic, malignant disease, pregnancy\                                                                                  Duration: 8 weeks\                                                                                                                                                 Anthropometric: Weight, BMI Metabolic: FG, FI        Moderate
                                                                                           BMI 36.6 ± 5.1\                     BMI 35.8 ± 4.8\                 Non-PCOS 44%                                                                                                         Non-PCOS: history gestational diabetes, family history abnormal glucose tolerance, hypertension, dyslipidemia                                                                                                                                             Standardized hypocaloric diet (50% carbohydrate, 20% protein, 30% fat) with 500--1000 kcal/day deficit.\                                                                                                                
                                                                                           Modified ESHRE/ASRM\                *n* = 15                                                                                                                                                                                                                                                                                                                                                                                                       No modification of physical activity or other weight loss methods.\                                                                                                                                                     
                                                                                           *n* = 16                                                                                                                                                                                                                                                                                                                                                                                                                                           Aim of weight loss: Yes                                                                                                                                                                                                 

  Kogure 2016 \[[@B44-nutrients-09-00996]\]                Comparative study   Brazil      Age 28.1 ± 5.4\                     Age 29.6 ± 5.2\                 PCOS 38%\               No hormonal contraceptive us drugs pre or during study                                       Systemic diseases, smoking, pregnancy                                                                                                                                                                                                                     Duration: 4 months\                                                                                                                                                Anthropometric: Weight, BMI, WC, TFFM, % body fat\   Moderate
                                                                                           BMI 28.4 ± 6.0\                     BMI 26.2 ± 5.7\                 Non-PCOS 46%                                                                                                                                                                                                                                                                                                                                                                   Progressive resistance training (PRT) for 1 h/day three times per week.\                                                                                           Reproductive: T, SHBG, FAI\                          
                                                                                           ESHRE/ASRM\                         *n* = 52                                                                                                                                                                                                                                                                                                                                                                                                       Aim of weight loss: not stated                                                                                                                                     Metabolic: FG, FI, HOMA-IR                           
                                                                                           *n* = 45                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Villa 1999 \[[@B40-nutrients-09-00996]\]                 Comparative study   Italy       Age 26.3 ± 5\                       Age not reported\               Not reported            Not reported                                                                                 Not reported                                                                                                                                                                                                                                              Duration: 4--5 weeks\                                                                                                                                              Anthropo-metric: BMI\                                High
                                                                                           BMI 27.5 ± 6.8\                     BMI 27.4 ± 6.8\                                                                                                                                                                                                                                                                                                                                                                                                50 mg Naltrexone daily\                                                                                                                                            Reproductive: T, SHBG, FAI\                          
                                                                                           NIH\                                *n* = 14                                                                                                                                                                                                                                                                                                                                                                                                       Aim of weight loss: not stated                                                                                                                                     Metabolic: FG, FI                                    
                                                                                           *n* = 22                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Kowalska 2001 \[[@B33-nutrients-09-00996]\]              Comparative study   Poland      Age 25.3 ± 4.8\                     Age 27.9 ± 7.3\                 PCOS 27%\               Not reported                                                                                 No additional                                                                                                                                                                                                                                             Duration: 4--5 months\                                                                                                                                             Anthropo-metric: BMI, WC\                            High
                                                                                           BMI 34.7 ± 6.0\                     BMI 36.2 ± 6.0\                 Non-PCOS 40%                                                                                                                                                                                                                                                                                                                                                                   Hypocaloric diet (1200--1400 kcal/day), Metformin 500 mg three times daily\                                                                                        Reproductive: T, FAI, SHBG\                          
                                                                                           NIH\                                *n* = 19                                                                                                                                                                                                                                                                                                                                                                                                       Aim of weight loss: not stated                                                                                                                                     Metabolic: FI                                        
                                                                                           *n* = 11                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Panidis 2014 \[[@B35-nutrients-09-00996]\]\              Comparative study   Greece      Age 26.1 ± 6.4\                     Age 31.5 ± 4.7\                 Not reported            No hormonal or insulin-sensitising drugs pre or during study                                 Galactorrea                                                                                                                                                                                                                                               Duration: 6 months\                                                                                                                                                Anthropo-metric: WC, BMI\                            High
  Vosnakis 2013 \[[@B36-nutrients-09-00996]\]\                                             BMI 34.5 ± 5.9\                     BMI 34.9 ± 5.4\                                                                                                                                                                                                                                                                                                                                                                                                Normal protein, energy-restricted diet (600 kcal/day energy deficit, moderate intensity aerobic exercise, 1 h × 3 times/week, Orlistat 120 mg before each meal)\   Reproductive: T, FAI, SHBG\                          
  Panidis 2008 \[[@B37-nutrients-09-00996]\]                                               ESHRE/ASRM\                         *n* = 29                                                                                                                                                                                                                                                                                                                                                                                                       Aim of weight loss: Yes                                                                                                                                            Metabolic: FG, lipids                                
                                                                                           *n* = 101                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Kahal 2015 \[[@B41-nutrients-09-00996]\]                 Comparative study   UK          Age 33.9 ± 6.7\                     Age 33.5 ± 7.1\                 PCOS 32%\               No medication                                                                                Alcohol intake \>14 units/week\                                                                                                                                                                                                                           Duration: 6 months\                                                                                                                                                Anthropometric: Weight, BMI                          High
                                                                                           BMI 37.9 ± 5.0\                     BMI 36.5 ± 4.6\                 Non-PCOS 29%                                                                                                         Non-PCOS: history of hirsutism or menstrual irregularities                                                                                                                                                                                                Liraglutide 0.6 mg o.d subcutaneous injection for 1 week, 1.2 mg o.d for 1 week, and 1.8 mg o.d thereafter for 6 months. No diet or exercise advice given.\                                                             
                                                                                           ESHRE/ASRM\                         *n* = 12                                                                                                                                                                                                                                                                                                                                                                                                       Aim of weight loss: Yes                                                                                                                                                                                                 
                                                                                           *n* = 13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Nikokavora 2015 \[[@B42-nutrients-09-00996]\]            Comparative study   UK          Age 35.7 ± 8.9\                     Age 35.8 ± 8.9\                 PCOS 73%\               Not reported                                                                                 Type 1 diabetes, porphyria, lactose intolerance, major cardio- or cerebrovascular disease, history of renal or hepatic disease, cancer, epilepsy, major psychological or eating disorders, breastfeeding, pregnant, birth or miscarriage prior 3 months   Duration: 12 weeks\                                                                                                                                                Anthropometric: Weight, BMI                          High
                                                                                           BMI 40.0 ± 6.3\                     BMI 40.0 ± 6.3\                 Non-PCOS 73%                                                                                                                                                                                                                                                                                                                                                                   Commercial weight management program (LighterLife Total), 600 kcal (36% protein, 36% carbohydrate, 28% fat) as food packs alongside behavior change program\                                                            
                                                                                           Diagnostic criteria not reported\   *n* = 137                                                                                                                                                                                                                                                                                                                                                                                                      Aim of weight loss: Yes                                                                                                                                                                                                 
                                                                                           *n* = 137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Bhandari 2016 \[[@B45-nutrients-09-00996]\]              Comparative study   India       Age 27.8 ± 4.50\                    Age 29.3 ± 4.96\                Not reported            No hormonal, fertility or insulin-sensitising drugs pre or during study                      Systemic diseases like hypothyroidism or hyperprolactinaemia, surgical complications intra or post operatively                                                                                                                                            Duration: 6 months post-surgery Sleeve gastrectomy (bariatric surgery)\                                                                                            Anthropometric: Weight, BMI\                         High
                                                                                           BMI 42.5 ± 5.71\                    BMI 45.0 ± 6.11\                                                                                                                                                                                                                                                                                                                                                                                               Aim of weight loss: Yes                                                                                                                                            Other: Abnormal menstrual cycles                     
                                                                                           ESHRE/ASRM\                         *n* = 32                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                           *n* = 43                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Al-Eisa 2017 \[[@B46-nutrients-09-00996]\]               Comparative study   Egypt       Age 27.9 ± 4.1\                     Age 27.6 ± 5.7\                 Not reported            No hormonal drugs pre or during study                                                        Normal BMI, other diseases such as diabetes or viral infections                                                                                                                                                                                           Duration: 12 weeks\                                                                                                                                                Anthropometric: Weight, BMI, WC\                     High
                                                                                           BMI 33.5 ± 2.75\                    BMI 31.7 ± 3.8\                                                                                                                                                                                                                                                                                                                                                                                                treadmill walking, 45 min three times per week for 12 weeks. Aim of weight loss: Yes                                                                               Metabolic: FG, FI                                    
                                                                                           ESHRE/ASRM\                         *n* = 30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                           *n* = 30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              RCT                 Italy       BMI \> 28\                          BMI \> 28\                      Diet: PCOS 0%\          No hormonal or insulin-sensitising drugs pre study                                           Diabetes, renal or liver dysfunction                                                                                                                                                                                                                      Duration: 6 months\                                                                                                                                                Anthropo-metric: Weight, BMI, SAT, VAT\              Moderate
                                                                                           WHR \> 0.80\                        WHR \> 0.80\                    Non-PCOS 25%\                                                                                                                                                                                                                                                                                                                                                                  One month hypocaloric diet (1200--1400 kcal daily), Metformin 850 mg twice daily.\                                                                                 Reproductive: T, SHBG\                               
                                                                                           NIH\                                *n* = 17                        Metform-in: PCOS 17%\                                                                                                                                                                                                                                                                                                                                                          Aim of weight loss: Yes                                                                                                                                            Metabolic: FG, FI                                    
                                                                                           *n* = 18                                                            Non-PCOS 0%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Toscani 2011 \[[@B39-nutrients-09-00996]\]               RCT                 Brazil      Age 22.7 + 5.68\                    Age 29.4 + 5.74\                Not reported            No hormonal drugs pre study                                                                  Diabetes, renal dysfunction                                                                                                                                                                                                                               Duration: 2 months\                                                                                                                                                Anthropo-metric: Weight, WC, BMI\                    High
                                                                                           Most participants BMI ≥ 25\         Most participants\                                                                                                                                                                                                                                                                                                                                                                                             Diet 1: HP (30% protein, 40% carbohydrate, 30% fat)\                                                                                                               Reproductive: T, SHBG, FAI\                          
                                                                                           NIH\                                BMI ≥ 25\                                                                                                                                                                                                                                                                                                                                                                                                      Diet 2: NP (15% protein, 55% carbohydrate, 30% fat)\                                                                                                               Metabolic: BP, FG, 2HRG, FI, 2HRI, lipids            
                                                                                           *n* = 18                            *n* = 22                                                                                                                                                                                                                                                                                                                                                                                                       Aim of weight loss: Yes                                                                                                                                                                                                 
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2HRG: 2 h glucose; 2HRI: 2 h insulin; BMI, body mass index; BMR, basal metabolic rate; BP, blood pressure; FAI, free androgen index; FG, fasting glucose; FI, fasting insulin; IL-6, interleukin-6; PCOS, polycystic ovary syndrome; SAT, subcutaneous abdominal tissue; SCFAT, subcutaneous fat; SHBG, sexual-hormone binding globulin; T, total testosterone; TFFM, total fat free mass; TFM, total fat mass; TNF-α, tumor necrosis factor-α; VAT, visceral abdominal tissue; VF, visceral fat; WC, waist circumference.

nutrients-09-00996-t002_Table 2

###### 

Anthropometric outcomes.

  Outcome                                                  Reference                                                                     Intervention       Baseline PCOS: Mean ± SD   Baseline Non-PCOS: Mean ± SD   *p*-Value \*                  Post-Intervention PCOS: Mean ± SD   Post-Intervention Non-PCOS: Mean ± SD   *p*-Value \*
  -------------------------------------------------------- ----------------------------------------------------------------------------- ------------------ -------------------------- ------------------------------ ----------------------------- ----------------------------------- --------------------------------------- --------------
  **Weight (kg)**                                          Pasquali 2000 \[[@B38-nutrients-09-00996]\]                                   Hypocaloric diet   102 ± 19                   106 ± 13                       NR                            97 ± 18                             100 ± 13                                NR
  Cheang 2016 \[[@B43-nutrients-09-00996]\]                Hypocaloric diet                                                              99.2 ± 13.3        97.6 ± 15.4                0.7508                         −4.08 ± 3.65                  −4.69 ± 2.98                        0.6281                                  
  Moran 2007 \[[@B34-nutrients-09-00996]\]                 Hypocaloric diet                                                              95.1 ± 19.3        95.5 ± 16.5                NS                             −3.9 ± 3.6                    −4.5 ± 4.1                          0.642                                   
  Toscani 2011 \[[@B39-nutrients-09-00996]\]               High protein diet                                                             74.62 ± 18.8       75.89 ± 13.49              NR                             71.4 ± 15.45                  74.54 ± 13.71                       NR                                      
  Toscani 2011 \[[@B39-nutrients-09-00996]\]               Normal protein diet                                                           82.85 ± 15.18      77.51 ± 13.31              NR                             79.82 ± 16.51                 74.31 ± 13.88                       NR                                      
  Nikokavoura 2015 \[[@B42-nutrients-09-00996]\]           VLCD + behaviour change                                                       108.3 ± 18.1       107.4 ± 19.8               0.713                          89.8 ± 16.7                   88.0 ± 17.6                         0.19                                    
  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  103 ± 18           101 ± 8                    NR                             94 ± 17                       88 ± 7                              NR                                      
  Kahal 2015 \[[@B41-nutrients-09-00996]\]                 AO drug (Liraglutide)                                                         102.1 ± 17.1       100.4 ± 15.1               NS                             −3.0 ± 4.2                    −3.8 ± 3.4                          0.56                                    
  Bhandari 2016 \[[@B45-nutrients-09-00996]\]              Bariatric surgery                                                             106.89 ± 17.79     117.03 ± 19.89             NR                             77.27 ± 10.72                 84.89 ± 13.18                       NR                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 100.5 ± 4.5 ^!^    96.2 ± 3.5 ^!^             0.42                           95.3 ± 4.8 ^!^                96.9 ± 4.5 ^!^                      NR                                      
  Kogure 2016 \[[@B44-nutrients-09-00996]\]                Progressive resistance training                                               73.1 ± 15.6        68.1 ± 15.4                NS                             0.52 \[−0.31, 1.36\] ^\^^     0.13 \[−0.64, 0.90\] ^\^^           0.14                                    
  Al−Eisa 2017 \[[@B46-nutrients-09-00996]\]               Aerobic training                                                              89.8 ± 6.95        84.9 ± 7.2                 NR                             84.8 ± 6.42                   82.2 ± 5.72                         NR                                      
  **BMI (kg/m^2^)**                                        Pasquali 2000 \[[@B38-nutrients-09-00996]\]                                   Hypocaloric diet   39.6 ± 6.9                 40.1 ± 6.2                     NR                            38 ± 6.2                            37.8 ± 5.7                              NR
  Cheang 2016 \[[@B43-nutrients-09-00996]\]                Hypocaloric diet                                                              36.6 ± 5.1         35.8 ± 4.8                 0.6507                         −1.46 \[−0.72, −2.20\] ^\#^   −1.80 \[−1.14, −2.45\] ^\#^         0.4829                                  
  Nikokavoura 2015 \[[@B42-nutrients-09-00996]\]           VLCD + behaviour change                                                       40.0 ± 6.3         40.0 ± 6.3                 0.955                          33.2 ± 6.0                    32.8 ± 5.7                          NR                                      
  Kowalska 2001 \[[@B33-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  34.7 ± 6.0         36.2 ± 6.0                 NS                             31.4 ± 4.8                    35.8 ± 7.9                          NR                                      
  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  39.8 ± 7.9         37.4 ± 3.0                 NR                             36.4 ± 7.4                    32.9 ± 3.4                          NR                                      
  Diamanti−Kandarakis 2007 \[[@B30-nutrients-09-00996]\]   Hypocaloric diet + AO drug (Orlistat)                                         35·43 ± 5·31       36·39 ± 6·47               0.58                           29.7 ± 4.57                   30.15 ± 4.13                        NR                                      
  Vosnakis 2013 \[[@B36-nutrients-09-00996]\]              Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   34.83 ± 6.39       36.79 ± 6.98               NR                             30.21 ± 5.78                  31.01 ± 4.93                        NR                                      
  Kahal 2015 \[[@B41-nutrients-09-00996]\]                 AO drug (Liraglutide)                                                         37.9 ± 5.0         36.5 ± 4.6                 NS                             −1.0 ± 1.5                    −1.4 ± 1.2                          0.43                                    
  Villa 1999 \[[@B40-nutrients-09-00996]\]                 AO drug (Naltrexone)                                                          27.5 ± 6.8         27.4 ± 6.8                 NS                             26.8 ± 6.7                    27 ± 6.8                            NR                                      
  Bhandari 2016 \[[@B45-nutrients-09-00996]\]              Bariatric surgery                                                             42.52 ± 5.66       45.03 ± 6.3                0.0717                         30.76 ± 2.93                  32.67 ± 3.51                        0.013                                   
  Hutchison 2001 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 37.4 ± 1.5 ^!^     35.7 ± 1.3 ^!^             0.43                           35 ± 1.6 ^!^                  35.9 ± 1.8 ^!^                      NR                                      
  Kogure 2016 \[[@B44-nutrients-09-00996]\]                Progressive resistance training                                               28.4 ± 6.0         26.2 ± 5.7                 NS                             0.21 \[−0.11, 0.54\] \^       0.05 \[−0.25, 0.35\] \^             0.08                                    
  Al−Eisa 2017 \[[@B46-nutrients-09-00996]\]               Aerobic training                                                              33.45 ± 2.75       31.7 ± 3.8                 NR                             28.5 ± 2.25                   26.8 ± 2.54                         NR                                      
  **WC (cm)**                                              Pasquali 2000 \[[@B38-nutrients-09-00996]\]                                   Hypocaloric diet   109 ± 19                   109 ± 11                       NR                            104 ± 13                            105 ± 12                                NR
  Toscani 2011 \[[@B39-nutrients-09-00996]\]               High protein diet                                                             87.74 ± 14.08      83.92 ± 9.13               \<0.05                         86 ± 12.92                    81.83 ± 9.13                        NR                                      
  Toscani 2011 \[[@B39-nutrients-09-00996]\]               Normal protein diet                                                           93.32 ± 8.05       84.02 ± 9.03               \<0.05                         90.03 ± 10.41                 81.7 ± 11.72                        NR                                      
  Kowalska 2001 \[[@B33-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  98.1 ± 14.8        102.3 ± 13.0               NS                             93.4 ± 11.8                   100 ± 19.5                          NR                                      
  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  107 ± 16           102 ± 6                    NR                             100 ± 15                      94 ± 6                              NR                                      
  Panidis 2008 \[[@B37-nutrients-09-00996]\]               Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   101.52 ± 2.67      100.53 ± 3.94              NS                             87.86 ± 2.29                  87.67 ± 2.82                        NR                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 106.8 ± 3.4 ^!^    102.8 ± 2.6 ^!^            0.39                           103.1 ± 4 ^!^                 99.9 ± 4.1 ^!^                      NR                                      
  Kogure 2016 \[[@B44-nutrients-09-00996]\]                Progressive resistance training                                               81.7 ± 12.8        76.2 ± 11.3                \<0.05                         0.86 \[0.32, 1.40\] \^        0.27 \[−0.21, 0.75\]                0.21                                    
  Al−Eisa 2017 \[[@B46-nutrients-09-00996]\]               Aerobic training                                                              96.2 ± 3.52        94.2 ± 3.82                NR                             93.8 ± 3.26                   72.7 ± 2.6                          NR                                      
  **VAT/VF (cm^2^)**                                       Pasquali 2000 \[[@B38-nutrients-09-00996]\]                                   Hypocaloric diet   121 ± 48                   181 ± 94                       NR                            108 ± 36                            159 ± 83                                NR
  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  151 ± 91           133 ± 38                   NR                             113 ± 59                      100 ± 37                            NR                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 129.2 ± 12.8 ^!^   121.5 ± 9.4 ^!^            0.65                           107.6 ± 15.1 ^!^              132.7 ± 18.1 ^!^                    NR                                      
  **SAT/SCFAT (cm^2^)**                                    Pasquali 2000 \[[@B38-nutrients-09-00996]\]                                   Hypocaloric diet   589 ± 127                  554 ± 118                      NR                            574 ± 111                           508 ± 107                               NR
  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  535 ± 147          554 ± 79                   NR                             485 ± 170                     462 ± 81                            NR                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 590.2 ± 35.2 ^!^   550.3 ± 45.2 ^!^           0.49                           538.4 ± 40.2 ^!^              558.5 ± 74.5 ^!^                    NR                                      

\* Between-group difference; ^!^ mean ± SEM; \^ estimated difference \[95% confidence interval\]; ^\#^ mean \[95% confidence interval\]; AO, anti-obesity; BMI, body mass index; NR, not reported; NS, not significant; PCOS, polycystic ovary syndrome; SAT, subcutaneous adipose tissue area; SCFAT, subcutaneous fat; VAT, visceral adipose tissue area; VF, visceral fat; VLCD, very low calorie diet; WC, waist circumference.
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###### 

Reproductive outcomes.

  Outcome                                                  References                                                                    Intervention                   Baseline PCOS: Mean ± SD   Baseline Non-PCOS: Mean ± SD   *p*-Value \*              Post-intervention PCOS: Mean ± SD   Post-intervention Non-PCOS: Mean ± SD   *p*-Value \*
  -------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------ -------------------------- ------------------------------ ------------------------- ----------------------------------- --------------------------------------- --------------
  **Number of ovulations**                                 Moran 2007 \[[@B34-nutrients-09-00996]\]                                      Hypocaloric diet               NR                         NR                             NR                        1.9 ovulations                      1.0 ovulations                          \<0.001
  **Total testosterone (nmol/L)**                          Pasquali 2000 \[[@B38-nutrients-09-00996]\]                                   Hypocaloric diet               1.77 ± 0.59                1.32 ± 0.42                    \<0.05                    1.63 ± 0.45                         1.14 ± 0.35                             NR
  Kowalska 2001 \[[@B33-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  3.57 ± 1.01                    1.91 ± 0.42                \<0.05                         2.39 ± 1.11               1.7 ± 0.59                          NR                                      
  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  2.36 ± 1.21                    1.46 ± 0.38                \<0.01                         1.7 ± 0.87                1.25 ± 0.38                         NR                                      
  Diamanti-Kandarakis 2007 \[[@B30-nutrients-09-00996]\]   Hypocaloric diet + AO drug (Orlistat)                                         3.01 ± 0.94                    1.50 ± 0.43                \<0.001                        2.28 ± 0.65               1.49 ± 0.36                         \<0.05                                  
  Panidis 2014 \[[@B35-nutrients-09-00996]\]               Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   2.56 ± 1.00                    1.33 ± 0.45                \<0.001                        2.1 ± 0.78                1.41 ± 0.74                         0.006                                   
  Villa 1999 \[[@B40-nutrients-09-00996]\]                 AO drug (Naltrexone)                                                          1.7 ± 0.5                      1.4 ± 0.5                  NS                             1.9 ± 1.76                1.5 ± 1.2                           NR                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 2.9 ± 0.2^!^                   1.6 ± 0.2 ^!^              \<0.01                         2.8 ± 0.3 ^!^             1.8 ± 0.3 ^!^                       NR                                      
  Kogure 2016 \[[@B44-nutrients-09-00996]\]                Progressive resistance training                                               3.12 ± 1.22                    2.58 ± 1.02                \<0.05                         0.59 \[0.30, 0.89\] \^    0.42 \[0.16, 0.68\] \^              0.15 ^\#^                               
  **SHBG (nmol/L)**                                        Pasquali 2000 \[[@B38-nutrients-09-00996]\]                                   Hypocaloric diet               16.0 ± 7.04                20.2 ± 10.7                    NS                        13.8 ± 2.1                          28.1 ± 14.7                             NR
  Kowalska 2001 \[[@B33-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  32.0 ± 18.3                    32.5 ± 16.5                NS                             38.6 ± 19.3               36.5 ± 13.3                         NR                                      
  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  18.7 ± 15.0                    23.4 ± 22.7                NS                             16.7 ± 8.1                28.9 ± 16.5                         NR                                      
  Diamanti-Kandarakis 2007 \[[@B30-nutrients-09-00996]\]   Hypocaloric diet + AO drug (Orlistat)                                         28.72 ± 12.48                  40.92 ± 19.54              0.01                           37.21 ± 17.59             58.6 ± 27.02                        \<0.05                                  
  Panidis 2014 \[[@B35-nutrients-09-00996]\]               Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   30.3 ± 13.2                    47.8 ± 34.7                0.012                          40.3 ± 20.4               62.2 ± 35.5                         NS                                      
  Villa 1999 \[[@B40-nutrients-09-00996]\]                 AO drug (Naltrexone)                                                          30.2 ± 20.4                    38.2 ± 16.4                NS                             32.5 ± 20.9               39.2 ± 15.7                         NR                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 29.0 ± 1.8^!^                  43.6 ± 7.8 ^!^             0.04                           30.7 ± 2.8 ^!^            54.3 ± 10.6 ^!^                     NR                                      
  Kogure 2016 \[[@B44-nutrients-09-00996]\]                Progressive resistance training                                               54.9 ± 37.8                    63.0 ± 35.7                NS                             0.12 \[0.02, 0.23\] \^    0.09 \[−0.01, 0.18\] \^             0.37 ^\#^                               
  **FAI**                                                  Kowalska 2001 \[[@B33-nutrients-09-00996]\]                                   Hypocaloric diet + Metformin   14.49 ± 8.49               9.97 ± 7.95                    \<0.05                    9.31 ± 9.95                         5.49 ± 3.9                              NR
  Panidis 2014 \[[@B35-nutrients-09-00996]\]               Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   10.25 ± 6.31                   3_71 ± 2.11                \<0.001                        6.76 ± 4.32               2.71 ± 1.74                         0.021                                   
  Villa 1999 \[[@B40-nutrients-09-00996]\]                 AO drug (Naltrexone)                                                          9.3 ± 6.5                      4.9 ± 3.1                  \<0.05                         8.9 ± 5.7                 5.2 ± 3.3                           NR                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 10.7 ± 1.1 ^!^                 4.6 ± 0.9 ^!^              \<0.01                         10.1 ± 1.6 ^!^            4.1 ± 1.1 ^!^                       NR                                      
  Kogure 2016 \[[@B44-nutrients-09-00996]\]                Progressive resistance training                                               8.3 ± 6.3                      5.6 ± 4.6                  \<0.05                         0.98 \[−0.03, 1.99\] \^   0.37 \[−0.50, 1.24\] \^             0.25 ^\#^                               

\* Between-group difference; ^!^ mean ± SEM; \^ estimated difference \[95% confidence interval\]; ^\#^ *p* value adjusted for age, BMI, and HOMA-IR; AO, anti-obesity; FAI, free androgen index; NR, not reported; NS, not significant; PCOS, polycystic ovary syndrome; SHBG, sex hormone-binding globulin.

nutrients-09-00996-t004_Table 4

###### 

Glucose and insulin homeostasis.

  Outcome                                                  References                                                                    Intervention                Baseline PCOS: Mean ± SD   Baseline Non-PCOS: Mean ± SD   *p*-Value \*                Post-Intervention PCOS: Mean ± SD   Post-Intervention Non-PCOS: Mean ± SD   *p*-Value \*
  -------------------------------------------------------- ----------------------------------------------------------------------------- --------------------------- -------------------------- ------------------------------ --------------------------- ----------------------------------- --------------------------------------- --------------
  **Fasting glucose (mmol/L)**                             Pasquali 2000 \[[@B38-nutrients-09-00996]\]                                   Hypocaloric diet            5.61 ± 1.0                 5.11 ± 0.56                    NS                          5.27 ± 0.61                         5.16 ± 0.94                             NR
  Cheang 2016 \[[@B43-nutrients-09-00996]\]                Hypocaloric diet                                                              4.75 ± 0.45                 4.67 ± 0.21                0.60                           −0.06 (−0.25, 0.12) ^%^     0.01 (−0.13, 0.15) ^%^              0.5041                                  
  Toscani 2011 \[[@B39-nutrients-09-00996]\]               High protein diet                                                             4.97 ± 0.34                 4.95 ± 0.45                NS                             5.02 ± 0.40                 5.05 ± 0.54                         NR                                      
  Toscani 2011 \[[@B39-nutrients-09-00996]\]               Normal protein diet                                                           4.90 ± 0.36                 4.98 ± 0.41                NS                             4.98 ± 0.35                 5.02 ± 0.35                         NR                                      
  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  5.49 ± 1.61                 4.94 ± 0.56                NS                             5 ± 0.94                    4.94 ± 0.72                         NR                                      
  Diamanti-Kandarakis 2007 \[[@B30-nutrients-09-00996]\]   Hypocaloric diet + AO drug (Orlistat)                                         5.72 ± 0.51                 5.77 ± 0.61                0.92                           5.52 ± 0.47                 5.69 ± 0.52                         NR                                      
  Panidis 2014 \[[@B35-nutrients-09-00996]\]               Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   5.58 ± 0.57                 5.81 ± 0.66                NS                             5.28 ± 0.56                 5.58 ± 0.51                         NS                                      
  Villa 1999 \[[@B40-nutrients-09-00996]\]                 AO drug (Naltrexone)                                                          4.65 ± 0.33                 4.55 ± 0.22                NS                             4.33 ± 0.56                 4.48 ± 0.37                         NR                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 5.0 ± 0.1 ^!^               4.8 ± 0.1 ^!^              0.57                           4.9 ± 0.1 ^!^               4.9 ± 0.1 ^!^                       NR                                      
  Kogure 2016 \[[@B44-nutrients-09-00996]\]                Progressive resistance training                                               5.34 ± 0.91                 5.31 ± 0.97                NS                             0.37 \[0.08, 0.66\] \$      0.30 \[0.04, 0.56\] \$              0.12 \*\*                               
  Al-Eisa 2017 \[[@B46-nutrients-09-00996]\]               Aerobic training                                                              4.50 ± 2.80                 5.59 ± 1.57                NR                             4.50 ± 2.80                 5.59 ± 1.57                         NR                                      
  **OGTT-glucose (mmol/L)**                                Toscani 2011 \[[@B39-nutrients-09-00996]\]                                    High protein diet           6.27 ± 1.60                5.02 ± 0.99                    NR                          6.92 ± 2.0                          5.63 ± 1.56                             NR
  Toscani 2011 \[[@B39-nutrients-09-00996]\]               Normal protein diet                                                           6.55 ± 1.50                 5.41 ± 1.02                NR                             6.64 ± 2.16                 5.18 ± 1.02                         NR                                      
  Diamanti-Kandarakis 2007 \[[@B30-nutrients-09-00996]\]   Hypocaloric diet + AO drug (Orlistat)                                         6.35 ± 1.35                 6.54 ± 1.54                0.65                           6.17 ± 0.85                 6.21 ± 1.77                         NR                                      
  **Fasting insulin (pmol/L)**                             Pasquali 2000 \[[@B38-nutrients-09-00996]\]                                   Hypocaloric diet            240.36 ± 214.53            149.24 ± 79.64                 NS                          136.33 ± 103.32                     103.32 ± 76.06                          NR
  Toscani 2011 \[[@B39-nutrients-09-00996]\]               High protein diet                                                             76.05 (60.00--123.41) \^    57.85 (28.20--84.94) \^    \<0.05                         61.67 (52.71--108.83) \^    56.74 (33.20--97.92) \^             NR                                      
  Toscani 2011 \[[@B39-nutrients-09-00996]\]               Normal protein diet                                                           128.83 (93.06--213.28) \^   59.59 (41.04--84.52) \^    \<0.05                         129.15 (76.99--233.04) \^   48.00 (31.14--80.14) \^             NR                                      
  Pasquali 2000 \[[@B38-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  308.53 ± 218.12             217.40 ± 58.84             NS                             154.98 ± 223.86             102.6 ± 60.99                       NR                                      
  Kowalska 2001 \[[@B33-nutrients-09-00996]\]              Hypocaloric diet + Metformin                                                  26.2 ± 13.9 ^\#^            18.3 ± 14.2 ^\#^           \<0.05                         16.9 ± 9.1 ^\#^             20.0 ± 13.5 ^\#^                    NR                                      
  Diamanti-Kandarakis 2007 \[[@B30-nutrients-09-00996]\]   Hypocaloric diet + AO drug (Orlistat)                                         127.37 ± 61.12              125.5 ± 87.09              0.45                           76.4 ± 34.93                77.02 ± 47.3                        NR                                      
  Panidis 2014 \[[@B35-nutrients-09-00996]\]               Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   129.87 ± 75.01              133.34 ± 161.82            NS                             81.08 ± 50.94               68.16 ± 40.18                       NS                                      
  Villa 1999 \[[@B40-nutrients-09-00996]\]                 AO drug (Naltrexone)                                                          99.7 ± 75                   104.3 ± 63.1               NS                             90.4 ± 61                   85.3 ± 39.4                         NR                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]             Intensified exercise training                                                 141.6 (100.8--181.2) \^     72.6 (58.8--115.8) \^      0.02                           97.8 (66.6--231.0) \^       115.2 (76.2--177.6) \^              NR                                      
  Kogure 2016 \[[@B44-nutrients-09-00996]\]                Progressive resistance training                                               64.59 ± 47.92               36.11 ± 31.25              \<0.05                         0.90 \[−0.21, 1.94\] ^\$^   −0.90 \[−1.88, 0.07\] ^\$^          0.58 \*\*                               
  Al-Eisa 2017 \[[@B46-nutrients-09-00996]\]               Aerobic training                                                              17.8 ± 4.20 ^@^             20.6 ± 8.2 ^@^             NR                             14.8 ± 2.9 ^@^              16.1 ± 5.1 ^@^                      NR                                      

\* Between-group difference; ^!^ mean ± SEM; \^ median (IQ range); ^\#^ IU/L; ^@^ data reported as mU/mL (as per original study); ^%^ mean (95% confidence interval); ^\$^ estimated difference \[95% confidence interval\]; \*\* *p* value adjusted for age, BMI, and HOMA-IR; AO, anti-obesity; f-glucose, fasting glucose; f-insulin, fasting insulin; NR, not reported; NS, not significant; OGTT-glucose, oral glucose tolerance test glucose; PCOS, polycystic ovary syndrome.

nutrients-09-00996-t005_Table 5

###### 

Lipids and blood pressure.

  Outcome                                        References                                                                    Intervention           Baseline PCOS: Mean ± SD   Baseline Non-PCOS: Mean ± SD   *p*-Value \*           Post-intervention PCOS: Mean ± SD   Post-intervention Non-PCOS: Mean ± SD   *p*-Value \*
  ---------------------------------------------- ----------------------------------------------------------------------------- ---------------------- -------------------------- ------------------------------ ---------------------- ----------------------------------- --------------------------------------- --------------
  **Total cholesterol (mmol/L)**                 Toscani 2011 \[[@B39-nutrients-09-00996]\]                                    High protein diet      4.60 ± 1.15                4.24 ± 0.71                    NR                     4.32 ± 1.12                         4.19 ± 0.82                             NR
  Toscani 2011 \[[@B39-nutrients-09-00996]\]     Normal protein diet                                                           4.31 ± 1.04            4.05 ± 1.13                NR                             4.02 ± 0.82            3.86 ± 1.36                         NR                                      
  Panidis 2014 \[[@B35-nutrients-09-00996]\]     Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   5.04 ± 1.00            5.48 ± 0.93                NS                             4.52 ± 0.82            4.55 ± 0.87                         \<0.001                                 
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]   Intensified exercise training                                                 5.0 ± 0.3 ^!^          4.7 ± 0.2 ^!^              0.81                           4.4 ± 0.2 ^!^          4.8 ± 0.4 ^!^                       NR                                      
  **LDL cholesterol (mmol/L)**                   Toscani 2011 \[[@B39-nutrients-09-00996]\]                                    High protein diet      3.91 ± 1.09                3.66 ± 0.61                    NR                     3.78 ± 1.1                          3.54 ± 0.76                             NR
  Toscani 2011 \[[@B39-nutrients-09-00996]\]     Normal protein diet                                                           3.62 ± 0.95            3.30 ± 1.11                NR                             3.33 ± 0.75            3.13 ± 1.34                         NR                                      
  Panidis 2014 \[[@B35-nutrients-09-00996]\]     Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   3.30 ± 0.90            3.65 ± 0.68                NS                             2.87 ± 0.84            2.98 ± 0.47                         0.001                                   
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]   Intensified exercise training                                                 3.3 ± 0.2 ^!^          3.0 ± 0.2 ^!^              0.48                           3 ± 0.2 ^!^            3.1 ± 0.4 ^!^                       NR                                      
  **HDL cholesterol (mmol/L)**                   Toscani 2011 \[[@B39-nutrients-09-00996]\]                                    High protein diet      1.30 ± 0.19                1.35 ± 0.38                    NR                     1.27 ± 0.2                          1.34 ± 0.39                             NR
  Toscani 2011 \[[@B39-nutrients-09-00996]\]     Normal protein diet                                                           1.19 ± 0.32            1.39 ± 0.26                NR                             1.18 ± 0.32            1.5 ± 0.25                          NR                                      
  Panidis 2014 \[[@B35-nutrients-09-00996]\]     Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic exercise   1.20 ± 0.22            1.32 ± 0.31                NS                             1.21 ± 0.23            1.21 ± 0.26                         0.006                                   
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]   Intensified exercise training                                                 1.0 ± 0.1 ^!^          1.2 ± 0.1 ^!^              0.04                           1 ± 0.1 ^!^            1.2 ± 0.1 ^!^                       NR                                      
  **Triglycerides (mmol/L)**                     Toscani 2011 \[[@B39-nutrients-09-00996]\]                                    High protein diet      0.86 (0.47--1.47) \^       0.68 (0.47--0.76) \^           NR                     0.55 (0.49--0.71) \^                0.92 (0.55--1.02) \^                    NR
  Toscani 2011 \[[@B39-nutrients-09-00996]\]     Normal protein diet                                                           0.97 (0.67--1.30) \^   0.71 (0.41--1.62) \^       NR                             0.94 (0.81--1.15) \^   0.88 (0.64--1.21) \^                NR                                      
  Panidis 2014 \[[@B35-nutrients-09-00996]\]     Hypocaloric diet + AO drug (Orlistat) + moderate intensity aerobic training   1.17 ± 0.56            1.28 ± 0.62                NS                             0.99 ± 0.44            0.87 ± 0.25                         NS                                      
  Hutchison 2011 \[[@B31-nutrients-09-00996]\]   Intensified exercise training                                                 1.4 ± 0.2 ^!^          1.2 ± 0.2 ^!^              0.46                           0.9 ± 0.1 ^!^          1.3 ± 0.1 ^!^                       NR                                      
  **BP systolic (mmHg)**                         Toscani 2011 \[[@B39-nutrients-09-00996]\]                                    High protein diet      125.7 ± 19.0               116.1 ± 10.41                  NR                     126 ± 23.1                          117.85 ± 10.18                          NR
  Toscani 2011 \[[@B39-nutrients-09-00996]\]     Normal protein diet                                                           119.1 ± 16.4           116.43 ± 10.3              NR                             119.36 ± 15.38         110.71 ± 7.32                       NR                                      
  Harrison 2012 \[[@B32-nutrients-09-00996]\]    Intensified exercise training                                                 108 ± 14.6 ^!^         118 ± 16.7 ^!^             NS                             109 ± 10.4 ^!^         116 ± 16.2 ^!^                      NR                                      
  **BP diastolic (mmHg)**                        Toscani 2011 \[[@B39-nutrients-09-00996]\]                                    High protein diet      77.9 ± 10.75               74.6 ± 8.46                    NR                     80 ± 11.2                           74 ± 8.83                               NR
  Toscani 2011 \[[@B39-nutrients-09-00996]\]     Normal protein diet                                                           78 ± 11.83             75.14 ± 9.6                NR                             77.82 ± 12.02          72.57 ± 7.72                        NR                                      
  Harrison 2012 \[[@B32-nutrients-09-00996]\]    Intensified exercise training                                                 72 ± 10.2 ^!^          75 ± 8.8 ^!^               NS                             69 ± 7.4 ^!^           73 ± 10.5 ^!^                       NR                                      

\* Between-group difference; ^!^ mean ± SEM; \^ median (IQ range); AO, anti-obesity; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NR, not reported; NS, not significant; PCOS, polycystic ovary syndrome.
